DRTS ALPHA TAU MEDICAL LTD

$DRTS Yesterday started with an ugly morning followed by a near full recovery that was nice to see, looking to see if thar strength continues today, definitely worth paying attention to.

Is $DRTS the best setup in biotech right now? You’ve got mandatory TA-90 index buying landing this week, right before the big glioblastoma readout at SNO on Nov 13 that follows the FDA expanding the trial to 20 patients, plus even more catalysts lined up before EOY.

$DRTS Setup this week is looking bullish. Price is way overdue to catch up to last week's double news drops (GBM expansion + Samsung Korea collab). Add in pre-positioning ahead of next week's TA index inclusion and we should see nice upward pressure. Let’s go!

$DRTS At the end of the day, Alpha DaRT technology is solid. Right now it just feels like low volume algo trading dragging things down, pure noise until the next real catalyst drops.

$DRTS Biotech shakeouts are designed to take shares from impatient retail right before major news/data cycles drop. Don't let algorithmic churn trick you into selling a top tier oncology pipeline at a discount.

$DRTS ​Algo sellers can play games, but the fundamental story keeps getting stronger. ​Partnership with Samsung Medical Center in South Korea (ranked #5 globally in oncology) for pancreatic cancer + expanding U.S. clinical footprint. Huge setup ahead.

$DRTS Alpha Tau Medical, an Israeli developer of an alpha-radiation cancer therapy, says the FDA-approved expansion of its U.S. recurrent glioblastoma trial from 10 to 20 patients may support a market submission, citing initial discussions. Size: $1.08B market value at $12.29 (16:00 ET Oct 16, 2026); $104.8M cash and deposits at June 30. Caveat: a single-arm feasibility and safety study; reported results cover its first 3 patients. Next: new data at SNO Nov 13; another interim analysis six months after the 5th patient's July treatment.

$DRTS I believe that the buying for the TA 90 is very significant, specially when the trading in Israel is at low volume

$DRTS 7 days until we are updated on at least the status of the first 3 patients in the REGAIN study at SNO.

$DRTS Getting beat up with the poor macro and interest rates going up as biotechs do. I still believe this is a groundbreaking therapy and longterm should see multiples from here.

$DRTS is officially heading into the TA-125 index this Thursday. Great boost for liquidity and putting $DRTS on institutional radars.

$DRTS Today should be the official announcement that $DRTS will join the TA 90 in a week. This will bring great recognition and a large amount of buying.

$DRTS 21 days until we learn (at least) a lot more about the status of the first 3 patients in the GBM trial. Could be the game changer.

$DRTS $SGMO $SLS - wow all 3 of these dropped out of nowhere - after being up - something rotten is going on

$DRTS plan on buying some more today. Just waiting to see where it will fall. Have a nice day everyone!

$DRTS lately the market for small caps has really been tough, and $DRTS has come down with the market, actually $DRTS has been doing better then other small caps and yesterday the market turned a little and the stock went up nicely, I can’t wait to see what happens when the great catalysts hit, starting with the announcement tomorrow that the company will join the TA90 index, that should bring in a lot of buying

$DRTS begins FDA approval to expand its Alpha DaRT U.S. recurrent glioblastoma REGAIN trial, with new data slated for SNO 2026.

$DRTS this is a beast waiting to be unleashed. Just need to get through this macro churn. Goodluck yall

Didn't think I'd get another chance to add to my $DRTS bag at these levels! Grabbing a few more shares before the next update.

$DRTS is meeting with large institutions. Those institutions are raising their price targets. The catalysts are coming. Get ready for the RUN UP!